CD47/SIRPA-BLOCKING AGENT ALX148
Marginal Zone Lymphoma
M.D. Anderson Cancer Centerprotein_peptidePhase 1/2
—
Rating in progress
CD47/SIRPA-BLOCKING AGENT ALX148 in Marginal Zone Lymphoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active